Trial of Reduced Alteplase Dose for Parapneumonic Effusion (TRAPPE) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Trial of Reduced Alteplase Dose for Parapneumonic Effusion (TRAPPE) — Stella

Home/Pleural Infection/

View on ClinicalTrials.gov

Recruiting

Back to Pleural Infection trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

Hong Kong

Chinese University of Hong Kong, Hong Kong, Hong Kong

Prince of Wales Hospital, Hong Kong, Hong Kong

Key details

Phase

Safety & dosing / Large-scale testing

Sponsor

Chinese University of Hong Kong

Enrollment target

~30 participants

Started

November 2024

Primary completion

March 2028

Age range

18 Years and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.